SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ulrike Baranyi, Andreas M. Farkas, Karin Hock, Benedikt Mahr, Birgit Linhart, Martina Gattringer, Margit Focke-Tejkl, Arnd Petersen, Fritz Wrba, Thomas Rülicke, Rudolf Valenta, Thomas Wekerle, Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy, EBioMedicine, 2016,

    CrossRef

  2. 2
    Diahann TSL Jansen, Hanane el Bannoudi, Ramon Arens, Kim LL Habets, Marjolijn Hameetman, Tom WJ Huizinga, Jeroen N. Stoop, René EM Toes, Abatacept decreases disease activity in the absence of CD4+ T cells in a collagen-induced arthritis model, Arthritis Research & Therapy, 2015, 17, 1

    CrossRef

  3. 3
    Pierre Gazeau, Valérie Devauchelle-Pensec, Pierre Pochard, Jacques-Olivier Pers, Alain Saraux, Yves Renaudineau, Divi Cornec, Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels, Rheumatology, 2015, kev417

    CrossRef

  4. 4
    Clemens Scheinecker, Blockade of co-stimulation in chronic inflammatory diseases, Wiener Medizinische Wochenschrift, 2015, 165, 1-2, 23

    CrossRef

  5. 5
    Michael Schiff, Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow, Current Treatment Options in Rheumatology, 2015, 1, 4, 334

    CrossRef

  6. 6
    Josef S. Smolen, Daniel Aletaha, Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges, Nature Reviews Rheumatology, 2015, 11, 5, 276

    CrossRef

  7. 7
    Martin Aringer, Josef S Smolen, Safety of off-label biologicals in systemic lupus erythematosus, Expert Opinion on Drug Safety, 2015, 14, 2, 243

    CrossRef

  8. 8
    A. Picchianti Diamanti, M. M. Rosado, M. Scarsella, V. Germano, E. Giorda, S. Cascioli, B. Laganà, R. D'Amelio, R. Carsetti, Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents, Clinical & Experimental Immunology, 2014, 177, 3
  9. 9
    Fabio E. Ospina, Andrés Agualimpia, Fabio Bonilla-Abadía, Carlos A. Cañas, Gabriel J. Tobón, Pneumocystis jiroveciiPneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept, Case Reports in Rheumatology, 2014, 2014, 1

    CrossRef

  10. 10
    Damian Maseda, Rachel H Bonami, Leslie J Crofford, Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis, Expert Review of Clinical Immunology, 2014, 10, 6, 747

    CrossRef

  11. 11
    Mariana H García-Hernández, Roberto González-Amaro, Diana Patricia Portales-Pérez, Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects, Immunotherapy, 2014, 6, 5, 623

    CrossRef

  12. 12
    D. Aeberli, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  13. 13
    Gillian M. Keating, Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis, Drugs, 2013, 73, 10, 1095

    CrossRef